Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2026-01-22 @ 1:32 PM
Study NCT ID:
NCT02029157
Status:
COMPLETED
Last Update Posted:
2017-10-09
First Post:
2013-12-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC)
Sponsor:
Kyowa Kirin Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01
Start Date Type:
None
Primary Completion Date:
2017-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-27
First Submit QC Date:
None
Study First Post Date:
2014-01-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-10-06
Last Update Post Date:
2017-10-09
Last Update Post Date Type:
ACTUAL